DOD, Autism Research Program, Idea Development Award | W81XWH 22 ARP IDA

FAQs: DoD Autism Research Program (ARP) FY22 Idea Development Award

What is the ARP FY22 Idea Development Award?

The Department of Defense Autism Research Program (ARP) FY22 Idea Development Award is a competitive research funding opportunity designed to advance the autism spectrum disorder (ASD) field by supporting bold, high-risk/high-reward research ideas. It is intended for projects that may be early in development but have a clear path to generating influential results, opening new lines of inquiry, or producing discoveries that can ultimately improve outcomes for people with ASD and their families or caregivers.

What type of research is this award trying to support?

This mechanism prioritizes innovative, original research that could significantly move the field forward. The solicitation emphasizes ideas that introduce a new paradigm, challenge existing assumptions, address problems from a fresh perspective, or use novel concepts, tools, methods, or technologies. Proposals that mainly extend prior work in a straightforward or incremental way are described as a poor fit for this award's intent.

Does the project need to be directly related to autism spectrum disorder (ASD)?

Yes. The proposed research must be directly relevant to ASD. However, supporting preliminary evidence may come from outside ASD research as long as it logically supports the ASD-relevant research direction being proposed.

Is preliminary data required?

Yes. Unlike some early-stage idea programs, this award requires preliminary data.

Do the preliminary data need to come from ASD research specifically?

No. The preliminary data do not have to originate within ASD research specifically. Evidence from outside the ASD field may be used if it credibly supports the ASD-relevant research direction.

Can unpublished data be used as preliminary support?

Yes. The opportunity allows unpublished results from the principal investigator(s), the research team, or named collaborators to be used as preliminary data.

What are the expectations around impact?

Impact is described as a central expectation of this award mechanism. The work should be positioned as an important and original contribution to ASD research and, over time, to ASD care. Even if immediate clinical impact is not feasible within the project period, the application is expected to explain how the research could influence future understanding, practice, or intervention pathways.

What does the program mean by "high-risk/high-reward"?

The award is intended for bold ideas that may be early in development and carry higher scientific risk, but that have the potential to produce influential results or critical discoveries. The application is still expected to demonstrate plausibility through preliminary data and a sound scientific rationale grounded in careful reasoning and a critical review of the literature.

How important is innovation to reviewers?

Innovation is described as a defining feature. Strong candidates are expected to present genuinely creative research that may introduce new paradigms, challenge assumptions, use novel tools or technologies, or adapt existing approaches in a way that substantially changes what becomes possible.

Are incremental extensions of prior work competitive?

The solicitation indicates that proposals mainly extending prior work in a straightforward or incremental way are not considered a good fit for the intent of this mechanism.

Does the opportunity encourage alignment with specific Areas of Interest?

Yes. Applicants are strongly encouraged to align their proposals with one of the FY22 ARP Career Development Award Areas of Interest. If a proposal does not fit those areas directly, the application is expected to make a clear case that it targets a pressing ASD-related problem, question, or unmet need.

What if my project does not align with the referenced Areas of Interest?

The application is expected to clearly justify why the project still targets a pressing ASD-related problem, question, or unmet need, even if it does not align directly with the FY22 ARP Career Development Award Areas of Interest.

How important is the research team to the review?

The solicitation treats the quality and composition of the research team as a major review consideration. It states that personnel are crucial and indicates that the team should have experience in ASD research, suggesting reviewers will consider whether investigators have the expertise needed to execute the project and interpret outcomes appropriately.

Is a biostatistician required?

The Department of Defense encourages including a biostatistician. This emphasis is tied to the program's focus on statistical rigor, appropriate powering and modeling decisions, and credible interpretation of results.

What does the solicitation say about statistical rigor?

The opportunity emphasizes the importance of a solid statistical plan. This signals that reviewers will look for rigor in study design and analysis so findings can be interpreted with confidence and considered meaningful for the field.

Is there an option for two principal investigators (PIs)?

Yes. The funding opportunity includes a Partnering PI Option intended to promote meaningful collaboration. Under this option, two investigators are designated as principal investigators, each receives a separate award, and both work together on one integrated, synergistic project.

How does the Partnering PI Option work administratively?

One investigator serves as the Initiating PI and handles most submission-related administrative responsibilities, while the other serves as the Partnering PI. The structure is meant to support a peer-to-peer partnership where both investigators jointly shape and execute the science.

Can the Partnering PI Option be used for a mentor-trainee arrangement?

No. The solicitation explicitly states that applications pairing a mentor and trainee in the Initiating PI and Partnering PI roles do not meet the intent of the Partnering PI Option.

Are multidisciplinary or multi-organization collaborations allowed?

Yes. Multidisciplinary and multi-organizational collaborations are allowed, supporting teams that combine complementary methods, populations, technologies, or clinical and basic science strengths.

What are the funding instruments for this opportunity?

The listing indicates that the funding instruments include both grants and cooperative agreements.

Who is offering this funding opportunity?

The opportunity is offered by the Department of Defense, Department of the Army, through USAMRAA.

What is the Funding Opportunity Number?

The Funding Opportunity Number is W81XWH 22 ARP IDA.

What program/category identifiers are provided?

The opportunity is categorized as discretionary and is listed under research and development, CFDA 12.420.

Who is eligible to apply?

Eligibility is described as unrestricted, meaning it is broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement.

How many awards are expected?

The posting indicates an expected four awards.

What was the closing date for this opportunity?

The original closing date shown is August 18, 2022.

Is there a maximum award amount (budget ceiling)?

The listing shows an award ceiling of 0. This typically signals that applicants should rely on the full solicitation for any budget limits or that ceilings may be handled in program guidance rather than in the summary record.

What level of justification is expected for the scientific premise?

Beyond preliminary data, the proposal is expected to be grounded in a sound scientific rationale built from careful reasoning and a critical review of the literature, demonstrating that the idea is plausible and worth investment despite the higher-risk nature.